KRYXANA Olaparib 200mg Tablets


Kryxana 200mg (Ribociclib) is an anticancer medicine used to treat breast cancer in postmenopausal women.  It inhibits the growth of cancer cells prevents it from spreading to other parts of the body.

Manufacturer : Novartis AG.


Strengths available :  200mg

Storage :  Store between 20 °C – 25 °C

Dosage :

Usual Adult Dose for Breast Cancer

600 mg orally once a day for 21 consecutive days followed by 7 days off treatment for a complete cycle of 28 days.

Comments: Refer to the manufacturer product information for dosing and administration recommendations for the co-administered aromatase inhibitor (e.g., letrozole).

Use: In combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HE`R2)-negative advanced or metastatic breast cancer.


Most common side effects are Fatigue, diarrhea, headache, back pain, nausea, vomiting, or loss of appetite


Pack of 21 Film coated tablets


There are no reviews yet.

Be the first to review “KRYXANA Olaparib 200mg Tablets”

Your email address will not be published. Required fields are marked *